OneDigital Investment Advisors LLC Makes New $16.52 Million Investment in CVS Health Corporation $CVS

Posted by Francis Steltz on Aug 17th, 2026

OneDigital Investment Advisors LLC acquired a new stake in CVS Health Corporation (NYSE:CVS – Free Report) in the second quarter, HoldingsChannel.com reports. The firm acquired 159,641 shares of the pharmacy operator’s stock, valued at approximately $16,515,000.

Several other institutional investors have also recently added to or reduced their stakes in CVS. Plato Investment Management Ltd purchased a new position in CVS Health during the second quarter worth about $5,339,000. Bell Investment Advisors Inc purchased a new stake in CVS Health in the 2nd quarter valued at about $44,000. AMG National Trust Bank purchased a new stake in CVS Health in the 2nd quarter valued at about $5,841,000. Simplicity Wealth LLC acquired a new position in shares of CVS Health during the 2nd quarter valued at about $3,937,000. Finally, Wealth Effects LLC purchased a new position in shares of CVS Health during the 2nd quarter worth about $664,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms recently issued reports on CVS. Deutsche Bank Aktiengesellschaft boosted their target price on shares of CVS Health from $88.00 to $92.00 and gave the company a “buy” rating in a report on Thursday, May 7th. Wells Fargo & Company lifted their price target on shares of CVS Health from $103.00 to $123.00 and gave the company an “overweight” rating in a report on Monday, July 13th. TD Cowen boosted their price objective on shares of CVS Health from $105.00 to $110.00 and gave the company a “buy” rating in a research note on Monday, May 11th. Weiss Ratings upgraded CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, August 5th. Finally, Cantor Fitzgerald increased their target price on CVS Health from $100.00 to $110.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 7th. Twenty-two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $106.75.

View Our Latest Stock Report on CVS Health

CVS Health Price Performance

CVS opened at $97.09 on Monday. CVS Health Corporation has a 52-week low of $67.42 and a 52-week high of $110.68. The company has a 50 day moving average of $102.52 and a two-hundred day moving average of $88.26. The company has a market cap of $124.18 billion, a P/E ratio of 25.69, a P/E/G ratio of 0.93 and a beta of 0.61. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS – Get Free Report) last issued its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, beating analysts’ consensus estimates of $1.87 by $0.71. The business had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The business’s revenue for the quarter was up 7.3% compared to the same quarter last year. During the same quarter last year, the firm posted $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, analysts expect that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were given a $0.665 dividend. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 annualized dividend and a yield of 2.7%. CVS Health’s dividend payout ratio (DPR) is 70.37%.

Insider Activity at CVS Health

In other CVS Health news, Director Larry Robbins sold 1,983,538 shares of the business’s stock in a transaction dated Tuesday, May 19th. The stock was sold at an average price of $94.45, for a total transaction of $187,345,164.10. Following the transaction, the director owned 6,213,261 shares in the company, valued at $586,842,501.45. The trade was a 24.20% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders sold a total of 3,372,000 shares of company stock worth $317,473,598 in the last 90 days. Insiders own 0.85% of the company’s stock.

CVS Health Company Profile

(Free Report)

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.